Timothy J Wiggins
CIK 1224438 · View on SEC EDGAR ↗
First SEC filing: Sept. 3, 2014 · Latest: Sept. 3, 2014
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 25, 2016 | CVSA | S 10b5-1 | 790 | $17.94 | $14,173 | 44,939 Direct | -1.73% | Disposed | 635.9% (price as of 2026-08-20) |
| Feb. 26, 2015 | CVSA | S 10b5-1 | 790 | $36.98 | $29,214 | 36,149 Direct | -2.14% | Disposed | 257.0% (price as of 2026-08-20) |
| Sept. 2, 2014 | CVSA | S 10b5-1 | 393 | $42.80 | $16,820 | 38,767 Direct | -1.00% | Disposed | 208.4% (price as of 2026-08-20) |
| Aug. 25, 2014 | CVSA | S 10b5-1 | 242 | $43.35 | $10,491 | 40,030 Direct | -0.60% | Disposed | 204.5% (price as of 2026-08-20) |
| Aug. 20, 2014 | CVSA | S 10b5-1 | 309 | $43.08 | $13,312 | 34,643 Direct | -0.88% | Disposed | 206.4% (price as of 2026-08-20) |
| June 13, 2014 | CVSA | S 10b5-1 | 1,183 | $43.06 | $50,940 | 34,952 Direct | -3.27% | Disposed | 206.6% (price as of 2026-08-20) |
| Feb. 26, 2013 | CVSA | P | 334 | $29.88 | $9,980 | 32,205 Direct | +1.05% | Acquired | 341.8% (price as of 2026-08-20) |
| Feb. 26, 2013 | CVSA | P | 665 | $29.96 | $19,923 | 31,871 Direct | +2.13% | Acquired | 340.6% (price as of 2026-08-20) |
| Feb. 14, 2013 | CVSA | P | 664 | $30.08 | $19,973 | 33,044 Direct | +2.05% | Acquired | 338.9% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 26, 2015 | CVSA | Non-qualified Stock Option (Right to Buy) | Common Stock (36,713) | $26.23 | Aug. 26, 2025 | 36,713 | Acquired |
| Aug. 26, 2015 | CVSA | Incentive Stock Option (Right to Buy) | Common Stock (3,812) | $26.23 | Aug. 26, 2025 | 3,812 | Acquired |
| Aug. 20, 2014 | CVSA | Non-qualified Stock Option (Right to Buy) | Common Stock (20,700) | $43.47 | Aug. 20, 2024 | 20,700 | Acquired |
| Aug. 20, 2014 | CVSA | Incentive Stock Option (Right to Buy) | Common Stock (2,300) | $43.47 | Aug. 20, 2014 | 2,300 | Acquired |
| Aug. 21, 2013 | CVSA | Incentive Stock Option (Right to Buy) | Common Stock (3,531) | $28.32 | Aug. 21, 2023 | 3,531 | Acquired |
| Aug. 21, 2013 | CVSA | Non-qualified Stock Option (Right to Buy) | Common Stock (28,844) | $28.32 | Aug. 21, 2023 | 28,844 | Acquired |
| Aug. 29, 2012 | CVSA | Non-qualified Stock Option (Right to Buy) | Common Stock (48,650) | $18.60 | Aug. 29, 2022 | 48,650 | Acquired |
| Feb. 24, 2012 | CVSA | Non-qualified Stock Option (Right to Buy) | Common Stock (2,763) | $36.99 | Feb. 24, 2022 | 2,763 | Acquired |
| Feb. 24, 2012 | CVSA | Incentive Stock Option (Right to Buy) | Common Stock (10,812) | $36.99 | Feb. 24, 2022 | 10,812 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2016 | $446,121 | — | — | — | $280,611 | — | $65,247 | $1,622,480 |
| 2015 | $428,962 | — | — | — | $252,403 | — | $67,105 | $1,570,972 |
| 2014 | $414,044 | — | — | — | $336,863 | — | $55,134 | $1,557,549 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.